Final dissertation, worth 60 M-level credits, to demonstrate students’ capacity to conduct and report a major piece of research work - Extended
Final dissertation, worth 60 M-level credits, to demonstrate students’ capacity to conduct and report a major piece of research work
Figure 9 shows that most respondents (77%, n=36) agreed or strongly agreed that within their clinical area the best way to disclose trial results to participants would be to send the results or lay summary by post. Four respondents (9%) disagreed or strongly disagreed with this. The least popular of the suggested methods was sharing results by telephone call from a clinician; 29 (62%) PIs disagreed or strongly disagreed that would be the best option, although five (11%) agreed that this was the best method. A telephone call from a nurse or research coordinator was viewed as slightly more acceptable, but a face-to-face meeting with either a clinician or nurse was preferred to telephone contact. There was limited support for providing results via a web or journal reference to participants.
Figure 9: PI opinion about how trial results are best provided to participants
Respondents were asked to select up to two preferred methods for providing feedback to participants. Figure 10 confirms the provision of trial results or summary by post as the most favoured method (31 of a total 79 responses, 39%). The least favoured method was by face-to-face meeting with the clinician. No-one preferred to share findings via a telephone call from a clinician.
Figure 10: Personal preference(s) of PIs for return of trial results to participants
Figure 11 illustrates the responses to three attitudinal questions about returning trial results. More than half of respondents (57%, n=27) agreed or strongly agreed that 'disclosure of trial results should be at the request of the participant rather than being an automatic process' although 11 (23%) disagreed with this and nine had no particular view.
Figure 11: Attitudes of PIs towards the process of returning trial results
The majority of respondents (74%, n=35) agreed that 'participants should be told at the start of a trial how and when they can obtain the trial results'. Three PIs disagreed with this statement and nine neither agreed nor disagreed. Twenty eight (60%) PIs agreed that 'informing patients of trial results encourages their participation in future research', though 16 people (34%) had no particular opinion about this.
Some variation in opinion was noted between investigators of different specialties e.g. three (38%) oncologists/haematologists agreed/strongly agreed that disclosure of trial results should be at the request of the participant (i.e. optional) compared with six (75%) anaesthetists. Four (50%) oncologists/haematologists disagreed with this statement compared with one (13%) anaesthetist (N=8 in both specialties). Numbers were too small to assess statistical significance.